Close Menu

NEW YORK – T2 Biosystems announced on Thursday that its preliminary 2019 fourth quarter revenues increased 67 percent year over year.

The Lexington, Massachusetts-based firm also said that John Sperzel has assumed the position of president and CEO of T2 Biosystems as of January 8, 2020. He replaces John McDonough in both roles.

Lastly, the company announced an exclusive distribution deal for its tests in Israel.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.